VOYA Investment Management
ELDN icon

VOYA Investment Management’s Eledon Pharmaceuticals ELDN Stock Holding History

VOYA Investment Management’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62.7K Buy
15,906
+2,690
+20% +$9.78K ﹤0.01% 2415
2026
Q1 		$40.7K Buy
13,216
+1,796
+16% +$4.23K ﹤0.01% 2297
2025
Q4 		$17.2K Hold
11,420
– – ﹤0.01% 2405
2025
Q3 		$29.6K Sell
11,420
-6,693
-37% -$19.6K ﹤0.01% 2423
2025
Q2 		$49.1K Buy
+18,113
New +$54.3K ﹤0.01% 2604

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 166.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ZP
Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

VOYA Investment Management's ELDN Position: Q2 2026 in Review

VOYA Investment Management increased its Eledon Pharmaceuticals (ELDN) stake by 20% in Q2 2026, buying an estimated $9.78K and bringing the position to 15,906 shares worth $62.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2415.

VOYA Investment Management first reported a position in ELDN in Q2 2025 and has held it in 5 quarters since. 160 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

  • VOYA Investment Management held 15,906 shares of Eledon Pharmaceuticals worth $62.7K as of Q2 2026.
  • VOYA Investment Management bought 2,690 Eledon Pharmaceuticals shares in Q2 2026, an estimated $9.78K.
  • Eledon Pharmaceuticals made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #2415 holding.
  • VOYA Investment Management first reported a position in Eledon Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 160 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.